GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lin Bioscience 6696.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

158.50

+7.09%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−TWD 1.36bn

FY2016FY2025

Free cash flow

−TWD 1.45bn

FY2016FY2025

Shareholders' equity

TWD 10.73bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue—————————TWD 190,000
Gross profit—−TWD 20.2m−TWD 17.9m−TWD 11.2m−TWD 4.4m−TWD 4.1m−TWD 4.3m——TWD 190,000
Research and developmentTWD 1.61bnTWD 1.10bnTWD 854.1mTWD 320.9mTWD 244.8mTWD 145.0mTWD 193.3mTWD 104.0mTWD 122.9mTWD 32.4m
Operating income−TWD 2.86bn−TWD 1.46bn−TWD 1.10bn−TWD 445.1m−TWD 338.3m−TWD 197.0m−TWD 238.2m−TWD 155.6m−TWD 161.3m−TWD 41.3m
Net income−TWD 1.36bn−TWD 744.3m−TWD 687.2m−TWD 313.5m−TWD 434.7m−TWD 151.8m−TWD 235.3m−TWD 138.5m−TWD 159.1m−TWD 42.2m
Diluted earnings per share-16.73-9.47-9.13-4.29-5.34-1.86-2.89-2.25-2.80-1.56

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 25.43bnTWD 5.53bnTWD 3.60bnTWD 1.85bnTWD 923.2mTWD 1.22bnTWD 248.7mTWD 395.3mTWD 542.5mTWD 526.9m
Cash and short-term investments—TWD 5.21bnTWD 3.26bnTWD 1.65bnTWD 806.8mTWD 1.09bnTWD 117.1mTWD 268.7mTWD 394.1mTWD 387.9m
Total liabilitiesTWD 291.2mTWD 173.2mTWD 167.7mTWD 116.1mTWD 470.3mTWD 308.9mTWD 106.0mTWD 17.9mTWD 25.3mTWD 49.0m
Debt—TWD 34.0mTWD 42.9mTWD 46.5mTWD 2.2mTWD 5.2mTWD 67.9m———
Shareholders' equityTWD 10.73bnTWD 2.85bnTWD 2.14bnTWD 1.23bnTWD 541.6mTWD 912.3mTWD 141.8mTWD 377.5mTWD 517.3mTWD 477.9m
Shares outstanding81m79m75m73m81m81m81m62m57m27m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 1.44bn−TWD 1.02bn−TWD 1.01bn−TWD 361.0m−TWD 289.8m−TWD 180.6m−TWD 209.7m−TWD 125.9m−TWD 247.7m−TWD 49.6m
Capital spending−TWD 8.2m−TWD 7.3m−TWD 2.0m−TWD 22.4m−TWD 2.1m−TWD 573,000−TWD 2.3m−TWD 935,000−TWD 35.0m−TWD 81.2m
Free cash flow−TWD 1.45bn−TWD 1.03bn−TWD 1.01bn−TWD 383.4m−TWD 292.0m−TWD 181.2m−TWD 212.0m−TWD 126.9m−TWD 282.6m−TWD 130.8m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Jun 2021
Gross profit——−TWD 9.6m−TWD 9.4m−TWD 8.5m−TWD 6.9m−TWD 4.2m—
Operating income−TWD 580.6m−TWD 822.3m−TWD 635.3m−TWD 320.7m−TWD 455.5m−TWD 328.4m−TWD 116.7m−TWD 79.2m
Net income−TWD 313.2m−TWD 397.4m−TWD 346.8m−TWD 384.8m−TWD 302.4m−TWD 216.1m−TWD 97.5m−TWD 238.9m
Diluted earnings per share-3.84-5.05-4.41-5.11-4.02-2.96-1.33-3.37
Cash from operations—−TWD 509.0m−TWD 509.0m−TWD 506.0m−TWD 506.0m−TWD 219.0m−TWD 141.0m—
Capital spending—−TWD 3.0m−TWD 3.0m——−TWD 14.0m−TWD 7.0m—
Free cash flow—−TWD 512.0m−TWD 512.0m——−TWD 233.0m−TWD 148.0m—
Total assetsTWD 5.49bnTWD 5.53bnTWD 4.51bnTWD 3.60bnTWD 2.20bnTWD 1.85bn——
Cash and short-term investmentsTWD 5.22bnTWD 5.21bnTWD 4.17bnTWD 3.26bnTWD 1.95bnTWD 1.65bn——
DebtTWD 14.6mTWD 32.2mTWD 14.8mTWD 27.7mTWD 13.5mTWD 10.3m——
Shareholders' equityTWD 2.84bnTWD 2.85bnTWD 2.54bnTWD 2.14bnTWD 1.27bnTWD 1.23bn——

Financial ratios

Data as of 21 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on equity-12.7%-26.1%-32.2%-25.4%-80.3%-16.6%—
Return on assets-5.4%-13.5%-19.1%-16.9%-47.1%-12.5%—
Free cash flow yield-10.5%-7.7%-8.0%-2.8%———
Earnings growth83.1%8.3%119.2%-27.9%186.3%-35.5%—
Current ratio58.18x34.45x24.69x20.94x1.74x3.62x—
Debt to equity—0.01x0.01x0.02x0.77x0.01x0.44x
Equity ratio42.2%51.7%59.4%66.6%58.7%74.9%—
Interest coverage-2812.04x-1456.22x-904.97x-508.72x-4764.46x-668.72x—
Buybacks as a share of market value-3.6%-4.4%-3.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Operating income85.8%70.7%—
Net income63.2%55.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-2.4-1.4-1.3-4.0-3.4-5.3-1.0-1.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.